BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1027244)

  • 1. [Factor XIII as a stimulator of thrombin activity].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1976; 22(4):562-6. PubMed ID: 1027244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of factor XIII by beta-thrombin].
    Umarova BA; Strukova SM
    Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prothrombin activation by immobilized thrombin].
    Strukova SM
    Biokhimiia; 1976 Apr; 41(4):643-9. PubMed ID: 1022290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of the anticoagulation system following intravenous administration of beta-thrombin].
    Strukova SM; Umarova BA; Semenova OA; Liapina LA; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1979 May; 65(5):702-6. PubMed ID: 456683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procoagulant properties of beta/gamma-thrombin].
    Semenova OA; Strukova SM
    Vopr Med Khim; 1982; 28(4):137-40. PubMed ID: 6810543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen matrix-bound clotting factors (CMBCF) promote healing-associated events independent of factor XIII in an in vitro model.
    Pohle T; Becker JC; Lügering A
    Wound Repair Regen; 2011 Nov; 19(6):687-92. PubMed ID: 22092839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
    Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the activation of human factor XIII.
    Sheltawy MJ; Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1972 Dec; 28(3):473-82. PubMed ID: 4675268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Change in factor XIII activity in plasma during thrombocyte aggregation].
    Pastorova VE; Umarova BA
    Biull Eksp Biol Med; 1975 Jul; 80(7):14-7. PubMed ID: 1227639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of prothrombin, modified by maleic anhydride, some properties of N-maleyl-thrombin with free alpha-amino groups].
    Strukova SM; Baskova IL; Orlova AS; Cherniak VIa; Kudriashov BA
    Biokhimiia; 1975; 40(4):838-43. PubMed ID: 1239312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
    Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
    Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting factor XIII assay by dansyl cadaverine incorporation.
    Sheltawy MJ; Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1972 Dec; 28(3):483-8. PubMed ID: 4675269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proteolysis of prothrombin by beta/gamma thrombin].
    Strukova SM; Semenova OA; Kudriashov BA
    Biull Eksp Biol Med; 1980 Apr; 89(4):430-3. PubMed ID: 7388159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization of factor XIII on collagen membranes.
    Blanchy BG; Coulet PR; Gautheron DC
    J Biomed Mater Res; 1986 Apr; 20(4):469-79. PubMed ID: 3700441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.